E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/14/2020 in the Prospect News Distressed Debt Daily.

Melinta Therapeutics official unsecured creditors committee appointed

By Caroline Salls

Pittsburgh, Jan. 14 – Melinta Therapeutics, Inc.’s official committee of unsecured creditors was appointed Tuesday by Regions 3 and 9 U.S. Trustee Andrew R. Vara, according to a notice filed with the U.S. Bankruptcy Court for the District of Delaware.

The committee members are Karen Kelly of Amplity, Inc. of Yardley, Pa.; Jacob Wright of TrialCard Inc. of Morrisville, N.C.; Sean Diver of Lonza, Ltd. of Morristown, N.J.; Steven P. Yova of bioMerieux, Inc. of Durham, N.C.; Jennifer Kettner of Veeva Systems, Inc. of Radnor, Pa.; Judy Rumpler of D2 Pharma Consulting LLC of Chesterfield, Md.; and John Maher of J. Knipper and Co., Inc. of Lakewood, N.J.

Melinta is an antibiotics company based in New Haven, Conn. The company filed bankruptcy on Dec. 27 under Chapter 11 case number 19-12748.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.